Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07212946) titled 'Ayahuasca and Esketamine for Major Depression' on Oct. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: University of Sao Paulo

Condition: Major Depression Severe

Intervention: Drug: Ayahuasca

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 30, 2022

Target Sample Size: 22

Countries of Recruitment: Brazil

To know more, visit https://clinicaltrials.gov/study/NCT07212946

Published by HT Digital Content Services with perm...